No evidence of germline PTEN mutations in familial prostate cancer

Similar Items

• No germline mutations in the dimerization domain of MXI1 in prostate cancer clusters. The CRC/BPG UK Familial Prostate Cancer Study Collaborators. Cancer Research Campaign/British Prostate Group.
  od: Edwards, S. M., i dr.
  Izdano: (1997)
• Two Percent of Men with Early-Onset Prostate Cancer Harbor Germline Mutations in the BRCA2 Gene
  od: Edwards, Stephen M., i dr.
  Izdano: (2003)
• Allelic imbalance in familial and sporadic prostate cancer at the putative human prostate cancer susceptibility locus, HPC1. CRC/BPG UK Familial Prostate Cancer Study Collaborators. Cancer Research Campaign/British Prostate Group.
  od: Dunsmuir, W. D., i dr.
  Izdano: (1998)
• Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis
  od: Edwards, S M, i dr.
  Izdano: (2010)
• HPC2/ELAC2 polymorphisms and prostate cancer risk: analysis by age of onset of disease
  od: Meitz, J C, i dr.
  Izdano: (2002)